Michael Laskowski, Ph. D. - Publications

Affiliations: 
1957-2004 Chemistry Purdue University, West Lafayette, IN, United States 

61 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Qasim MA, Wang L, Qasim S, Lu S, Lu W, Wynn R, Yi ZP, Laskowski M. Additivity-based design of the strongest possible turkey ovomucoid third domain inhibitors for porcine pancreatic elastase (PPE) and Streptomyces griseus protease B (SGPB). Febs Letters. 587: 3021-6. PMID 23892073 DOI: 10.1016/J.Febslet.2013.07.029  0.387
2010 Qasim MA, Song J, Markley JL, Laskowski M. Cleavage of peptide bonds bearing ionizable amino acids at P(1) by serine proteases with hydrophobic S(1) pocket. Biochemical and Biophysical Research Communications. 400: 507-10. PMID 20800580 DOI: 10.1016/J.Bbrc.2010.08.078  0.394
2006 Yi Z, Vitek O, Qasim MA, Lu SM, Lu W, Ranjbar M, Li J, Laskowski MC, Bailey-Kellogg C, Laskowski M. Functional evolution within a protein superfamily. Proteins. 63: 697-708. PMID 16463276 DOI: 10.1002/Prot.20871  0.419
2005 Kelly CA, Laskowski M, Qasim MA. The role of scaffolding in standard mechanism serine proteinase inhibitors Protein and Peptide Letters. 12: 465-471. PMID 16029159 DOI: 10.2174/0929866054395383  0.418
2005 Li J, Yi Z, Laskowski MC, Laskowski M, Bailey-Kellogg C. Analysis of sequence-reactivity space for protein-protein interactions. Proteins. 58: 661-71. PMID 15624216 DOI: 10.1002/Prot.20341  0.332
2004 Ganz PJ, Bauer MD, Sun Y, Fieno AM, Grant RA, Correa PE, Laskowski M, Saunders CW. Stabilized variant of Streptomyces subtilisin inhibitor and its use in stabilizing subtilisin BPN'. Protein Engineering, Design & Selection : Peds. 17: 333-9. PMID 15187224 DOI: 10.1093/Protein/Gzh045  0.387
2003 LASKOWSKI M, WIDOM JM, MCFADDEN ML, SCHERAGA HA. Differential ultraviolet spectra of insulin. Biochimica Et Biophysica Acta. 19: 581-2. PMID 13315339 DOI: 10.1016/0006-3002(56)90502-9  0.346
2003 Qasim MA, Lu W, Lu SM, Ranjbar M, Yi Z, Chiang YW, Ryan K, Anderson S, Zhang W, Qasim S, Laskowski M. Testing of the additivity-based protein sequence to reactivity algorithm. Biochemistry. 42: 6460-6. PMID 12767228 DOI: 10.1021/Bi027186U  0.353
2003 Song J, Laskowski M, Qasim MA, Markley JL. Two conformational states of Turkey ovomucoid third domain at low pH: three-dimensional structures, internal dynamics, and interconversion kinetics and thermodynamics. Biochemistry. 42: 6380-91. PMID 12767219 DOI: 10.1021/Bi034053F  0.325
2003 Song J, Laskowski M, Qasim MA, Markley JL. NMR determination of pKa values for Asp, Glu, His, and Lys mutants at each variable contiguous enzyme-inhibitor contact position of the turkey ovomucoid third domain. Biochemistry. 42: 2847-56. PMID 12627950 DOI: 10.1021/Bi0269512  0.301
2001 Lu SM, Lu W, Qasim MA, Anderson S, Apostol I, Ardelt W, Bigler T, Chiang YW, Cook J, James MN, Kato I, Kelly C, Kohr W, Komiyama T, Lin TY, ... ... Laskowski M, et al. Predicting the reactivity of proteins from their sequence alone: Kazal family of protein inhibitors of serine proteinases. Proceedings of the National Academy of Sciences of the United States of America. 98: 1410-5. PMID 11171964 DOI: 10.1073/Pnas.98.4.1410  0.337
2001 Bateman KS, Huang K, Anderson S, Lu W, Qasim MA, Laskowski M, James MN. Contribution of peptide bonds to inhibitor-protease binding: crystal structures of the turkey ovomucoid third domain backbone variants OMTKY3-Pro18I and OMTKY3-psi[COO]-Leu18I in complex with Streptomyces griseus proteinase B (SGPB) and the structure of the free inhibitor, OMTKY-3-psi[CH2NH2+]-Asp19I. Journal of Molecular Biology. 305: 839-49. PMID 11162096 DOI: 10.1006/Jmbi.2000.4343  0.441
2000 DONOVAN JW, LASKOWSKI M, SCHERAGA HA. Influenza of ionization of carboxyl groups on the ultraviolet absorption spectrum of lysozyme. Biochimica Et Biophysica Acta. 29: 455-6. PMID 13572380 DOI: 10.1016/0006-3002(58)90221-X  0.359
2000 Bateman KS, Anderson S, Lu W, Qasim MA, Laskowski M, James MN. Deleterious effects of beta-branched residues in the S1 specificity pocket of Streptomyces griseus proteinase B (SGPB): crystal structures of the turkey ovomucoid third domain variants Ile18I, Val18I, Thr18I, and Ser18I in complex with SGPB. Protein Science : a Publication of the Protein Society. 9: 83-94. PMID 10739250 DOI: 10.1110/Ps.9.1.83  0.34
1999 Nguyen TT, Qasim MA, Morris S, Lu CC, Hill D, Laskowski M, Sakanari JA. Expression and characterization of elastase inhibitors from the ascarid nematodes Anisakis simplex and Ascaris suum. Molecular and Biochemical Parasitology. 102: 79-89. PMID 10477178 DOI: 10.1016/S0166-6851(99)00088-2  0.349
1999 Qasim MA, Lu SM, Ding J, Bateman KS, James MN, Anderson S, Song J, Markley JL, Ganz PJ, Saunders CW, Laskowski M. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases. Biochemistry. 38: 7142-50. PMID 10353824 DOI: 10.1021/Bi990265U  0.381
1997 Qasim MA, Ganz PJ, Saunders CW, Bateman KS, James MN, Laskowski M. Interscaffolding additivity. Association of P1 variants of eglin c and of turkey ovomucoid third domain with serine proteinases. Biochemistry. 36: 1598-607. PMID 9048543 DOI: 10.1021/Bi9620870  0.383
1997 Lu W, Apostol I, Qasim MA, Warne N, Wynn R, Zhang WL, Anderson S, Chiang YW, Ogin E, Rothberg I, Ryan K, Laskowski M. Binding of amino acid side-chains to S1 cavities of serine proteinases. Journal of Molecular Biology. 266: 441-61. PMID 9047374 DOI: 10.1006/Jmbi.1996.0781  0.409
1997 Lu W, Qasim MA, Laskowski M, Kent SB. Probing intermolecular main chain hydrogen bonding in serine proteinase-protein inhibitor complexes: chemical synthesis of backbone-engineered turkey ovomucoid third domain. Biochemistry. 36: 673-9. PMID 9020764 DOI: 10.1021/Bi9625612  0.454
1994 Wells JA, Fairbrother WJ, Otlewski J, Laskowski M, Burnier J. A reinvestigation of a synthetic peptide (TrPepz) designed to mimic trypsin Proceedings of the National Academy of Sciences of the United States of America. 91: 4110-4114. PMID 8183880 DOI: 10.1073/Pnas.91.10.4110  0.427
1991 Ardelt W, Laskowski M. Effect of single amino acid replacements on the thermodynamics of the reactive site peptide bond hydrolysis in ovomucoid third domain. Journal of Molecular Biology. 220: 1041-1053. PMID 1880798 DOI: 10.1016/0022-2836(91)90370-L  0.433
1991 Musil D, Bode W, Huber R, Laskowski M, Lin TY, Ardelt W. Refined X-ray crystal structures of the reactive site modified ovomucoid inhibitor third domains from silver pheasant (OMSVP3*) and from Japanese quail (OMJPQ3*). Journal of Molecular Biology. 220: 739-55. PMID 1870129 DOI: 10.1016/0022-2836(91)90114-L  0.447
1990 Wynn R, Laskowski M. Inhibition of human beta-factor XIIa by squash family serine proteinase inhibitors. Biochemical and Biophysical Research Communications. 166: 1406-10. PMID 2306254 DOI: 10.1016/0006-291X(90)91023-L  0.3
1990 Laskowski M, Apostol I, Ardelt W, Cook J, Giletto A, Kelly CA, Lu WY, Park SJ, Qasim MA, Whatley HE. Amino acid sequences of ovomucoid third domain from 25 additional species of birds. Journal of Protein Chemistry. 9: 715-25. PMID 2073323 DOI: 10.1007/Bf01024766  0.323
1988 Hildebrandt PG, Copeland RA, Spiro TG, Otlewski J, Laskowski M, Prendergast FG. Tyrosine hydrogen-bonding and environmental effects in proteins probed by ultraviolet resonance Raman spectroscopy. Biochemistry. 27: 5426-33. PMID 3179264 DOI: 10.1021/Bi00415A007  0.304
1987 Wieczorek M, Park SJ, Laskowski M. Covalent hybrids of ovomucoid third domains made from one synthetic and one natural peptide chain. Biochemical and Biophysical Research Communications. 144: 499-504. PMID 3555488 DOI: 10.1016/S0006-291X(87)80537-5  0.41
1987 Kato I, Schrode J, Kohr WJ, Laskowski M. Chicken ovomucoid: determination of its amino acid sequence, determination of the trypsin reactive site, and preparation of all three of its domains Biochemistry. 26: 193-201. PMID 3548816 DOI: 10.1021/Bi00375A027  0.397
1987 Laskowski M, Kato I, Kohr WJ, Park SJ, Tashiro M, Whatley HE. Positive darwinian selection in evolution of protein inhibitors of serine proteinases. Cold Spring Harbor Symposia On Quantitative Biology. 52: 545-553. PMID 3502622 DOI: 10.1101/Sqb.1987.052.01.062  0.346
1987 Fujinaga M, Sielecki AR, Read RJ, Ardelt W, Laskowski M, James MNG. Crystal and molecular structures of the complex of α-chymotrypsin with its inhibitor Turkey ovomucoid third domain at 1.8 Å resolution Journal of Molecular Biology. 195: 397-418. PMID 3477645 DOI: 10.1016/0022-2836(87)90659-0  0.388
1986 Markley JL, Croll DH, Krishnamoorthi R, Ortiz-Polo G, Westler WM, Bogard WC, Laskowski M. One- and two-dimensional NMR spectral analysis of the consequences of single amino acid replacements in proteins. Journal of Cellular Biochemistry. 30: 291-309. PMID 3711152 DOI: 10.1002/Jcb.240300403  0.319
1986 Laskowski M. Protein inhibitors of serine proteinases--mechanism and classification. Advances in Experimental Medicine and Biology. 199: 1-17. PMID 3541508 DOI: 10.1007/978-1-4757-0022-0_1  0.491
1985 Wieczorek M, Otlewski J, Cook J, Parks K, Leluk J, Wilimowska-Pelc A, Polanowski A, Wilusz T, Laskowski M. The squash family of serine proteinase inhibitors. Amino acid sequences and association equilibrium constants of inhibitors from squash, summer squash, zucchini, and cucumber seeds. Biochemical and Biophysical Research Communications. 126: 646-52. PMID 3977882 DOI: 10.1016/0006-291X(85)90233-5  0.349
1985 Ardelt W, Laskowski M. Turkey ovomucoid third domain inhibits eight different serine proteinases of varied specificity on the same ...Leu18-Glu19 ... reactive site. Biochemistry. 24: 5313-5320. PMID 3907700 DOI: 10.1021/Bi00341A007  0.475
1983 Wieczorek M, Laskowski M. Formation of covalent hybrids from amino-terminal and carboxy-terminal fragments of two ovomucoid third domains. Biochemistry. 22: 2630-2636. PMID 6871151 DOI: 10.1021/Bi00280A006  0.439
1982 Weber E, Papamokos E, Bode W, Huber R, Kato I, Laskowski M. Crystallization, crystal structure analysis and molecular model of the third domain of Japanese quail ovomucoid, a Kazal type inhibitor. Journal of Molecular Biology. 149: 109-23. PMID 7310876 DOI: 10.1016/0022-2836(81)90263-1  0.317
1982 Empie MW, Laskowski M. Thermodynamics and kinetics of single residue replacements in avian ovomucoid third domains: effect on inhibitor interactions with serine proteinases. Biochemistry. 21: 2274-2284. PMID 7046785 DOI: 10.1021/Bi00539A002  0.41
1982 Fujinaga M, Read RJ, Sielecki A, Ardelt W, Laskowski M, James MN. Refined crystal structure of the molecular complex of Streptomyces griseus protease B, a serine protease, with the third domain of the ovomucoid inhibitor from turkey Proceedings of the National Academy of Sciences of the United States of America. 79: 4868-4872. PMID 6750612 DOI: 10.1073/Pnas.79.16.4868  0.389
1980 Estell DA, Laskowski M. Dermasterias imbricata trypsin 1: an enzyme which rapidly hydrolyzes the reactive-site peptide bonds of protein trypsin inhibitors. Biochemistry. 19: 124-131. PMID 7352972 DOI: 10.1021/Bi00542A019  0.721
1980 Estell DA, Wilson KA, Laskowski M. Thermodynamics and kinetics of the hydrolysis of the reactive-site peptide bond in pancreatic trypsin inhibitor (Kunitz) by Dermasterias imbricata trypsin 1. Biochemistry. 19: 131-7. PMID 6153265 DOI: 10.1021/Bi00542A020  0.712
1979 Homandberg GA, Laskowski M. Enzymatic resynthesis of the hydrolyzed peptide bond(s) in Ribonuclease S Biochemistry. 18: 586-592. PMID 33699 DOI: 10.1021/Bi00571A006  0.364
1977 Oda K, Laskowski M, Kress LF, Kowalski D. Human plasma α1-proteinase inhibitor: Temporary inhibition and multiple molecular forms of the complex with porcine trypsin Biochemical and Biophysical Research Communications. 76: 1062-1070. PMID 302702 DOI: 10.1016/0006-291X(77)90964-0  0.371
1976 Kowalski D, Laskowski M. Chemical-enzymatic insertion of an amino acid residue in the reactive site of soybean trypsin inhibitor (Kunitz). Biochemistry. 15: 1309-1315. PMID 1252450 DOI: 10.1021/Bi00651A022  0.509
1976 Kowalski D, Laskowski M. Chemical-enzymatic replacement of Ile64 in the reactive site of soybeen trypsin inhibitor (Kunitz). Biochemistry. 15: 1300-1309. PMID 1252449 DOI: 10.1021/Bi00651A021  0.478
1976 Kowalski D, Kroeker WD, Laskowski M. Mung bean nuclease I. Physical, chemical, and catalytic properties. Biochemistry. 15: 4457-63. PMID 9973 DOI: 10.1021/Bi00665A019  0.423
1973 Sealock RW, Laskowski M. Thermodynamics and kinetics of the reactive site peptide-bond hydrolysis in bovine pancreatic secretory trypsin inhibitor (Kazal). Biochemistry. 12: 3139-46. PMID 4738932 DOI: 10.1021/Bi00741A001  0.514
1973 Mattis JA, Laskowski M. pH dependence of the equilibrium constant for the hydrolysis of the Arg 63 -Ile reactive-site peptide bond in soybean trypsin inhibitor (Kunitz). Biochemistry. 12: 2239-45. PMID 4710580 DOI: 10.1021/Bi00736A009  0.43
1973 Kress LF, Laskowski M. Large scale purification of alpha-1 trypsin inhibitor from human plasma. Preparative Biochemistry & Biotechnology. 3: 541-552. PMID 4544472 DOI: 10.1080/00327487308061536  0.31
1972 Kowalski D, Laskowski M. Inactivation of enzymatically modified trypsin inhibitors upon chemical modification of the -amino group in the reactive site. Biochemistry. 11: 3451-9. PMID 5066441 DOI: 10.1021/Bi00768A019  0.418
1972 De Vonis Bidlingmeyer U, Leary TR, Laskowski M. Identity of the tryptic and alpha-chymotryptic reactive sites on soybean trypsin inhibitor (Kunitz). Biochemistry. 11: 3303-10. PMID 5065479 DOI: 10.1021/Bi00767A028  0.332
1971 Laskowski M, Sealock RW. 11 Protein Proteinase Inhibitors-Molecular Aspects The Enzymes. 3: 375-473. DOI: 10.1016/S1874-6047(08)60402-3  0.409
1969 Niekamp CW, Hixson HF, Laskowski M. Peptide-bod hydrolysis equilibria in native proteins. Conversion of virgin into modified soybean trypsin inhibitor. Biochemistry. 8: 16-22. PMID 5813404 DOI: 10.1021/Bi00829A004  0.466
1969 Sealock RW, Laskowski M. Enzymatic replacement of the arginyl by a lysyl residue in the reactive site of soybean trypsin inhibitor. Biochemistry. 8: 3703-10. PMID 5387527 DOI: 10.1021/Bi00837A032  0.444
1963 TROWBRIDGE CG, KREHBIEL A, LASKOWSKI M. SUBSTRATE ACTIVATION OF TRYPSIN. Biochemistry. 2: 843-50. PMID 14075124 DOI: 10.1021/Bi00904A037  0.67
1962 Lebowitz J, Laskowski M. Potentiometric Measurement of Protein-Protein Association Constants. Soybean Trypsin Inhibitor-Trypsin Association* Biochemistry. 1: 1044-1055. DOI: 10.1021/Bi00912A015  0.32
1961 Donovan JW, Laskowski M, Scheraga HA. The Effects of Charged Groups on the Chromophores of Lysozyme and of Amino Acids1,2,3 Journal of the American Chemical Society. 83: 2686-2694. DOI: 10.1021/Ja01473A022  0.38
1961 Laskowski M, Scheraga HA. Thermodynamic Considerations of Protein Reactions. III. Kinetics of Protein Denaturation1,2 Journal of the American Chemical Society. 83: 266-274. DOI: 10.1021/Ja01463A003  0.402
1960 Donovan JW, Laskowski M, Scheraga HA. Abnormal Ionizable Groups in Lysozyme1,2 Journal of the American Chemical Society. 82: 2154-2163. DOI: 10.1021/Ja01494A017  0.341
1960 Laskowski M, Ehrenpreis S, Donnelly TH, Scheraga HA. Equilibria in the Fibrinogen-Fibrin Conversion. V. Reversibility and Thermodynamics of the Proteolytic Action of Thrombin on Fibrinogen1,2 Journal of the American Chemical Society. 82: 1340-1348. DOI: 10.1021/Ja01491A016  0.39
1959 Gruen L, Laskowski M, Scheraga HA. Thermodynamics of the Ionization of the Lysyl Residue of Insulin1,2 Journal of the American Chemical Society. 81: 3891-3901. DOI: 10.1021/Ja01524A023  0.388
1959 Donovan JW, Laskowski M, Scheraga HA. Carboxyl group interactions in lysozyme Journal of Molecular Biology. 1: 293-296. DOI: 10.1016/S0022-2836(59)80036-X  0.365
1958 Ehrenpreis S, Laskowski M, Donnelly TH, Scheraga HA. Equilibria in the Fibrinogen-Fibrin Conversion. IV. Kinetics of the Conversion of Fibrinogen to Fibrin Monomer1,2 Journal of the American Chemical Society. 80: 4255-4263. DOI: 10.1021/Ja01549A034  0.391
Show low-probability matches.